Works by Prokof'ev, A. B.

Results: 17

Standardization of a Formulation of Timogar and Ferula Assa-Foetida Dry Resin Extract and its Biological Activity.
Published in:
Pharmaceutical Chemistry Journal, 2021, v. 55, n. 8, p. 787, doi. 10.1007/s11094-021-02495-w
By:
- Popova, O. A.;
- Bunyatyan, N. D.;
- Bobizoda, G. M.;
- Remezova, I. P.;
- Prokof'ev, A. B.;
- Evteev, V. A.
Publication type:
Article
Synthesis of H-Lys-Lys-Gly-OH Tripeptide and Study of Its Acute Toxicity.
Published in:
Pharmaceutical Chemistry Journal, 2020, v. 54, n. 9, p. 914, doi. 10.1007/s11094-020-02296-7
By:
- Popova, O. A.;
- Bunyatyan, N. D.;
- Bobizoda, G. M.;
- Samiev, M.;
- Prokof'ev, A. B.;
- Evteev, V. A.;
- Sernov, L. N.
Publication type:
Article
Validation of a Method for Assay of Excipients in Liposomal Medicinal Formulations of the Photosensitizer Lipophthalocyan.
Published in:
Pharmaceutical Chemistry Journal, 2020, v. 53, n. 10, p. 986, doi. 10.1007/s11094-020-02110-4
By:
- Lantsova, A. V.;
- Olefir, Yu. V.;
- Bunyatyan, N. D.;
- Sanarova, E. V.;
- Orlova, O. L.;
- Dmitrieva, M. V.;
- Polozkova, A. P.;
- Oborotova, N. A.;
- Ogai, M. A.;
- Khadzhieva, Z. D.;
- Nikolaeva, L. L.;
- Kompantsev, D. V.;
- Shevchenko, A. M.;
- Prokof'ev, A. B.
Publication type:
Article
Role of Drug – Drug Interactions in the Efficacy and Safety of Clarithromycin Treatment for Helicobacter Pylori Eradication.
Published in:
Pharmaceutical Chemistry Journal, 2019, v. 53, n. 8, p. 678, doi. 10.1007/s11094-019-02061-5
By:
- Serebrova, S. Yu.;
- Kareva, E. N.;
- Eremenko, N. N.;
- Prokof'ev, A. B.;
- Kurguzova, D. O.;
- Drozdov, V. N.;
- Lazareva, N. B.;
- Komissarenko, I. A.;
- Starodubtsev, A. K.
Publication type:
Article
Controversial Points in the Assessment of the Quality of Generic Esomeprazole Formulations.
Published in:
Pharmaceutical Chemistry Journal, 2019, v. 53, n. 1, p. 1, doi. 10.1007/s11094-019-01946-9
By:
- Serebrova, S. Yu.;
- Prokof'ev, A. B.;
- Krasnykh, L. M.;
- Vasilenko, G. F.;
- Smolyarchuk, E. A.;
- Kareva, E. N.;
- Smirnov, V. V.;
- Zhuravleva, M. V.;
- Eremenko, N. N.;
- Lazareva, N. B.;
- Starodubtsev, A. K.;
- Kurguzova, D. O.;
- Barkov, A. O.;
- Abrosimov, A. G.;
- Koniev, T. I.;
- Sivkov, A. S.;
- Temirbulatov, I. I.
Publication type:
Article
Validation of an Assay Procedure for Ormustine in a Liposomal Dosage Form.
Published in:
Pharmaceutical Chemistry Journal, 2018, v. 52, n. 9, p. 799, doi. 10.1007/s11094-018-1903-5
By:
- Bunyatyan, N. D.;
- Oborotova, N. A.;
- Nikolaeva, L. L.;
- Ignat'eva, E. V.;
- Yartseva, I. V.;
- Lantsova, A. V.;
- Prokof'ev, A. B.
Publication type:
Article
Synthesis and some Pharmacological Properties of an Immunoactive Lysine-Containing Tetrapeptide.
Published in:
Pharmaceutical Chemistry Journal, 2018, v. 52, n. 7, p. 611, doi. 10.1007/s11094-018-1869-3
By:
- Bunyatyan, N. D.;
- Kholnazarov, B. M.;
- Bobizoda, G. M.;
- Olefir, Yu. V.;
- Prokof'ev, A. B.;
- Sapovskii, M. M.;
- Evteev, V. A.
Publication type:
Article
Development of an HPLC-MS/MS Method for Quantitative Determination of Rivaroxaban in Human Blood Serum.
Published in:
Pharmaceutical Chemistry Journal, 2018, v. 52, n. 4, p. 372, doi. 10.1007/s11094-018-1824-3
By:
- Rodina, T. A.;
- Mel’nikov, E. S.;
- Aksenov, A. A.;
- Belkov, S. A.;
- Sokolov, A. V.;
- Prokof’ev, A. B.;
- Ramenskaya, G. V.
Publication type:
Article
HPLC-MS/MS Method for Determining Dabigatran in Human Blood Serum.
Published in:
Pharmaceutical Chemistry Journal, 2018, v. 51, n. 12, p. 1129, doi. 10.1007/s11094-018-1753-1
By:
- Rodina, T. A.;
- Mel’nikov, E. S.;
- Aksenov, A. A.;
- Belkov, S. A.;
- Sokolov, A. V.;
- Prokof’ev, A. B.;
- Ramenskaya, G. V.
Publication type:
Article
Simultaneous Determination of Metoprolol and Bisoprolol in Human Serum by HPLC-MS/MS for Clinical Drug Monitoring.
Published in:
Pharmaceutical Chemistry Journal, 2018, v. 51, n. 12, p. 1111, doi. 10.1007/s11094-018-1750-4
By:
- Rodina, T. A.;
- Mel’nikov, E. S.;
- Dmitriev, A. I.;
- Belkov, S. A.;
- Sokolov, A. V.;
- Arkhipov, V. V.;
- Prokof’ev, A. B.
Publication type:
Article
Validation of a Quantitative Determination Method for Ormustine in a Lyophilized Dosage Form.
Published in:
Pharmaceutical Chemistry Journal, 2018, v. 51, n. 11, p. 1037, doi. 10.1007/s11094-018-1735-3
By:
- Bunyatyan, N. D.;
- Nikolaeva, L. L.;
- Olefir, Yu. V.;
- Sanarova, E. V.;
- Oborotova, N. A.;
- Prokof’ev, A. B.;
- Ignat’eva, E. V.;
- Yartseva, I. V.;
- Gulyakin, I. D.
Publication type:
Article
Interchangeability Issues with Glaucoma Medicines Using Latanoprost as an Example.
Published in:
Pharmaceutical Chemistry Journal, 2018, v. 51, n. 11, p. 1021, doi. 10.1007/s11094-018-1732-6
By:
- Bunyatyan, N. D.;
- Filippova, O. V.;
- Romanov, B. K.;
- Prokof’ev, A. B.
Publication type:
Article
Analysis of Antitumor Activity of the Liposomal Photosensitizer Lipophthalocyan.
Published in:
Bulletin of Experimental Biology & Medicine, 2020, v. 168, n. 3, p. 361, doi. 10.1007/s10517-020-04709-9
By:
- Lantsova, A. V.;
- Borisova, L. M.;
- Meerovich, G. A.;
- Bunyatyan, N. D.;
- Olefir, Yu. V.;
- Prokof'ev, A. B.;
- Evteev, V. A.;
- Sapovskii, M. M.;
- Kiseleva, M. P.;
- Sanarova, E. V.;
- Orlova, O. L.;
- Dmitrieva, M. V.;
- Polozkova, A. P.;
- Oborotova, N. A.;
- Ogay, M. A.;
- Khadzhieva, Z. J.;
- Nikolaeva, L. L.
Publication type:
Article
Comparative Analysis of Bioactivity of the Russian-Made Antitumor Substances of the Nitrosourea Group.
Published in:
Bulletin of Experimental Biology & Medicine, 2019, v. 166, n. 6, p. 456, doi. 10.1007/s10517-019-04371-w
By:
- Bunyatyan, N. D.;
- Oborotova, N. A.;
- Nikolaeva, L. L.;
- Saprykina, N. S.;
- Borisova, L. M.;
- Kiseleva, M. P.;
- Prokof'ev, A. B.
Publication type:
Article
Comparative Analysis of Bioactivity of the Russian-Made Antitumor Substances of the Nitrosourea Group.
Published in:
Bulletin of Experimental Biology & Medicine, 2019, v. 166, n. 4, p. 456, doi. 10.1007/s10517-019-04371-w
By:
- Bunyatyan, N. D.;
- Oborotova, N. A.;
- Nikolaeva, L. L.;
- Saprykina, N. S.;
- Borisova, L. M.;
- Kiseleva, M. P.;
- Prokof’ev, A. B.
Publication type:
Article
Studies of the Possibility of Using Renal Biomarkers to Assess Drug Nephrotoxicity in an RPTEC/TERT1 Cell Line Model.
Published in:
Pharmaceutical Chemistry Journal, 2023, v. 57, n. 7, p. 953, doi. 10.1007/s11094-023-02970-6
By:
- Evteev, V. A.;
- Semenova, I. S.;
- Bunyatyan, N. D.;
- Prokof'ev, A. B.
Publication type:
Article
Simultaneous Determination of Dabigatran, Rivaroxaban, Apixaban, and Warfarin in Human Blood Serum by HPLC-MS/MS for Therapeutic Drug Monitoring.
Published in:
Pharmaceutical Chemistry Journal, 2022, v. 56, n. 2, p. 289, doi. 10.1007/s11094-022-02633-y
By:
- Rodina, T. A.;
- Melnikov, E. S.;
- Aksenov, A. A.;
- Belkov, S. A.;
- Sokolov, A. V.;
- Prokof'ev, A. B.;
- Ramenskaya, G. V.
Publication type:
Article